Slit2 Protein Composition for Reverse-Aging to Limit Tumorigenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-aging methods, such as those using OSKM, have significant side effects like tumorigenesis and cancer progression, necessitating the development of a safer alternative to reverse or prevent cellular aging.
Innovation Solution
Utilizing Slit2 protein, particularly Slit2-N, to induce reverse-aging or anti-aging in senescent cells by increasing cell growth and reducing inflammation-related gene expression, thereby addressing the limitations of existing methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If OSKM-based reverse aging method is used, then cellular aging is reversed and lifespan is extended, but tumorigenesis and cancer progression occur
Solution Approach 1:
The patent extracts and utilizes only the beneficial anti-aging function of young cells through Slit2 protein, separating it from the harmful effects of complete cellular reprogramming. By identifying and applying specifically the Slit2 protein that mediates the anti-aging effect, the invention eliminates the risk of tumorigenesis associated with OSKM while preserving the lifespan-extending benefits
Solution Approach 2:
The patent introduces Slit2 protein as an intermediary substance that transfers the anti-aging effect from young cells to senescent cells without requiring direct cellular reprogramming. This intermediary approach allows the beneficial effects to be transmitted while avoiding the harmful side effects of complete reprogramming
2Adaptability or versatility
If complete cellular reprogramming is performed, then cellular characteristics are reset, but cancer formation is induced
Solution Approach 1:
The patent applies partial action by using only the specific Slit2 protein component that provides anti-aging benefits, rather than performing complete cellular reprogramming with all four OSKM factors. This partial approach achieves sufficient cellular rejuvenation while avoiding the excessive action that leads to cancer formation
Data Source
AI summary
A reverse-aging or anti-aging composition containing Slit2 proteins, a pharmaceutical composition containing same for the prevention or treatment of cellular senescence-related diseases, and/or cosmetic composition containing same for anti-aging are disclosed. Also, a method for inducing reverse-aging of senescent cells, including the step of treating senescent cells with Slit2 proteins is disclosed. The composition, by minimizing tumor formation and cancer progression which are the side effects of conventional reverse-aging induction methods, may be useful as a composition for reverse-aging or anti-aging and/or a method for inducing reverse-aging.